HMNC Brain Health
M├╝nchen
About HMNC Brain Health
HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders. Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specific therapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $37.5M
- Last round: Series Unknown (Oct 2022)
- Website: hmnc-brainhealth.com
- Phone: +49 (0)89 - 255 437 150
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/hmnc-brain-health-76304 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.